NASDAQ:BVXV
Delisted
BiondVax Pharmaceuticals Ltd. Stock News
$1.36
+0 (+0%)
At Close: Dec 05, 2023
First Participant Enrolled in Second Cohort of BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial
09:45am, Monday, 08'th Jul 2019
JERUSALEM, July 8, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (BVXV) announced today that the first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the
European Investment Bank VP Attends Signature Event at BiondVax Extending Financing Agreement With BiondVax to €24million
02:51pm, Wednesday, 26'th Jun 2019
JERUSALEM, June 26, 2019 /PRNewswire/ -- The Board of Directors and Management of BiondVax Pharmaceuticals Ltd. (BVXV), was honored to host Mr. Ambroise Fayolle, Vice-President of the European Investm
BiondVax Gets OK to Build Plant in Israel (BVXV)
01:37pm, Tuesday, 25'th Jun 2019
BiondVax Pharmaceuticals Ltd. (BVXV) secured a grant from the Israel Investment Center, a unit of the Government of Israel's Ministry of Economy and Industry, to build a manufacturing facility for th
